Sorrento Therapeutics Inc (SRNE)

[dia76ca]

It will be interesting to see if Sorrento's cancer portfolio will benefit from the latest FDA move. The FDA oncology chief aims to open up accelerated approval for earlier cancer treatment under 'Project FrontRunner'.

For decades, the FDA has been offering accelerated approvals to open early access to new cancer drugs, but mostly for patients who’ve already tried several other regimens. FDA oncology chief Richard Pazdur, M.D., now plans to disrupt that longstanding practice with a new initiative.

Called “Project Front-Runner,” the new program will come online later this year, Pazdur, director of the FDA’s Oncology Center of Excellence, told Fierce Biotech in an interview. Although details are still in the works, the program’s theme is clear—to advance accelerated approval to earlier cancer treatment.

https://www.fiercebiotech.com/biotech/fda-oncology-chief-eyes-accelerated-approval-earlier-cancer-treatment-under-planned-project